Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed, page-6

I believe you are correct Fattchoi - isn’t this the Independent Trial? Obviously those who understand trial regulation will comment with knowledge.
Its tremendous to see this next phase of a Hervaxx treatment for breast cancer as I believe it was the subject of trial 1B with Phase 2 moved to test it on gastric cancer under the stewardship of LC. So this further testing on breast cancer is exciting for the potential it bring to patients. Maybe this bring those who enrol in the trial a step closer to refined and effective treatment with limited side effects.
Indeed a special thanks to the patients who enrol in the trials for IMU in particular as you must be on a roller coaster of stress, hope and reservation. Let’s hope you can see life beyond another injection.